07/10/2023
is a unique nano-silver preparation formulated with proven efficacy as an antimicrobial and antiviral product.
SilverSol is produced using a patented technology that uniquely captures silverโs antimicrobial activity effectively. The individual silver nanoparticle (NP) contains elemental (zero-valent) metallic silver coated with silver oxide and has an optimum particle size ranging from 5 to 50 nm. The technology achieves unique tetrahedral molecular arrangement of silver with oxygen, giving rise to a broad range of properties.
The key properties of SilverSol, viz. multidimensional efficacy at extremely low concentration, prolonged stability and absence of adverse side effects make it โthe product of choiceโ in wound healing.
Several products of SilverSol both for oral administration and topical application are available world-wide in gel, liquid and cream form and other application-oriented forms.
These products are outstanding with proven efficacy in various ailments besides wound healing viz. malaria, various bacterial, fungal, viral infections including HIV, influenza virus, vaginal infection, severe infectious conditions due to resistant bacteriaโMRSA (Methicillin Resistant Staphylococcus aureus) and VRE (Vancomycin Resistant Enterococci).
SILVERSOL techology is most widely used as a wound healing agent, both for external applications and for oral administration with detailed attributes of SilverSol in terms of safety, efficacy and pharmacology. Its physicochemical properties, mechanism of action and its regulatory status are also well known.
Several wounds of varied etiology and severity have been successfully treated with SilverSol without the formation of dermal fibrotic lesions, demonstrating its efficacy in wound healing.
Remarkable effects were associated with less post-operative/surgical pain and oedema, less post-operative complications, prevention of bacterial and fungal infection and removal of biofilms, which collectively resulted into quicker healing.
๐ฟ๐ง ๐. ๐. ๐๐๐ง๐ก๐๐ ๐๐ง
https://bit.ly/3ZdnTY4
